Business Finland provides €3 Million Loan to Forendo Pharma for Developing Novel Treatments for Endometriosis
Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces that it has been granted a €3 million R&D loan...
Italian pharmaceutical R & D excellence presented at the 33rd Congress of the European Association of Urology
Fidia Farmaceutici announced the positive results of a Phase II study evaluating the efficacy and tolerability of Oncofid®PB, an innovative anti-cancer cell-directed paclitaxel-hyaluronan bioconjugate...
Biogen plans to present its advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting
Biogen Inc. announced that it will present at the Advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting.
A plenary session titled “The Importance...
Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity
Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks...
Urgo Medical: The Clinical Trial EXPLORER is the First Study to Demonstrate the Efficacy of a Dressing (Urgostart®) in Diabetic Foot Ulcer Healing
UrgoStart® heals 60% more patients compared to a well-managed standard treatment, and reduces healing time by 60 days (compared to the average healing time...
Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular diseases, today announced...
Micell Technologies Announces Expanded Patent Estate
Micell® Technologies, Inc., a privately-held, development-stage biomedical company, provided an update on its recently expanded intellectual property portfolio. With the granting of 24 patents...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...